目的分析江苏省启东市1972—2021年老年人群恶性肿瘤死亡流行特征,为制定老年恶性肿瘤精准防控策略提供科学依据。
方法数据资料来源于启东癌症登记报告系统,采用描述性研究方法,计算老年人群(≥60岁)恶性肿瘤死亡率,中标率采用2000年中国标准人口年龄构成,世标率采用Segi's世界标准人口年龄构成计算。使用Joinpoint 4.9.1.0软件计算死亡率的年度变化百分比(APC)和平均年度变化百分比(AAPC)。
结果1972—2021年启东市老年人群恶性肿瘤死亡74 723例,粗死亡率为752.08/10万,中标率为666.03/10万(男性994.22/10万,女性470.29/10万),世标率为681.11/10万。中标率在2000年以前波动较小,2001—2011年快速上升,2011—2021年则有所下降。2017—2021年粗死亡率为791.01/10万,中标率为689.80/10万(男性956.77/10万,女性469.98/10万),世标率为657.53/10万。2012—2021年,启东市60~64岁、65~69岁、70~74岁、75~79岁、80+岁年龄组的恶性肿瘤死亡率分别为385.42/10万、505.51/10万、721.64/10万、1 213.28/10万、1 705.32/10万,<75岁老年人2012—2021年死亡率均低于其他时期,而≥75岁老年人2012—2021年死亡率均高于其他时期。1972—2021年恶性肿瘤总体中标死亡率的AAPC值为0.22%,其中2008—2021年APC值为-1.59%(均 P<0.05)。50年间死亡例数前5位的恶性肿瘤是肺癌、胃癌、肝癌、结直肠癌和食管癌,中标率的AAPC值分别为1.61%、-2.36%、-0.10%、1.44%、-2.03%,其中肺癌和结直肠癌死亡率的上升趋势、胃癌和食管癌死亡率的下降趋势有统计学意义( P<0.05)。
结论启东市老年人群恶性肿瘤死亡率处于较高水平,2008年起老年恶性肿瘤总体死亡率呈下降趋势,部分恶性肿瘤的防控已显成效。
ObjectiveTo analysis the prevalence characteristics of cancer mortality among the elderly in Qidong City, Jiangsu Province, from 1972 to 2021, and to provide scientific basis for the development of precise prevention and control strategies for cancer in the elderly.
MethodsData of cancers were obtained from Qidong Cancer Registry, a descriptive study method was used to calculate the crude mortality rate (CMR) of cancer among the elderly (≥60 years old). The China age-standardized rate (ASR-C) was calculated using the age structure of the Chinese population in 2000, and world age-standardized rate (ASR-W) was calculated using Segi's world standard population. Joinpoint regression analysis was performed using Joinpoint 4.9.1.0 software to calculate the annual percentage change (APC) and average annual percentage change (AAPC) of mortality.
ResultsFrom 1972 to 2021, there were 74 723 cancer deaths in the elderly in Qidong, with CMR of 752.08/10 5, ASR-C of 666.03/10 5 (994.22/10 5 for males and 470.29/10 5 for females) and ASR-W of 681.11/10 5. The ASR-C showed little fluctuation before 2000, increased rapidly from 2001 to 2011, and then decreased from 2011 to 2021. From 2017 to 2021, the CMR was 791.01/10 5, the ASR-C was 689.80/10 5 (956.77/10 5 for males and 469.98/10 5 for females), and the ASR-W was 657.53 /10 5. The CMR for the 60-64, 65-69, 70-74, 75-79, and 80+ age groups from 2012 to 2021 were 385.42/10 5 505.51/10 5, 721.64/10 5, 1 213.28/10 5, and 1 705.32/10 5, respectively. The CMR of elderly under 75 years old were lower from 2012 to 2021 than in other periods, while those of elderly people aged more than 75 years were higher from 2012 to 2021 than in other periods. The AAPC for ASR-C of all cancers over the 50 years was 0.22%, with APC of -1.59% in 2008-2021 (both P<0.05). Over the 50 years, the top five cancers in terms of mortality were lung cancer, gastric cancer, liver cancer, colorectal cancer, and esophageal cancer. Their AAPCs of ASR-C were 1.61%, -2.36%, -0.10%, 1.44%, and -2.03%, respectively. The increasing trends of mortality rates for lung cancer and colorectal cancer and the decreasing trends for gastric cancer and esophageal cancer were statistically significant ( P<0.05).
ConclusionsThe mortality of cancers among elderly is at a high level in Qidong. The overall mortality since 2008 have shown a decreasing trend, and the prevention and control of some cancers have been effective.
陈永胜,王军,唐小慧,等. 江苏省启东市1972—2021年老年人群恶性肿瘤死亡流行特征[J]. 中华肿瘤杂志,2025,47(03):237-243.
DOI:10.3760/cma.j.cn112152-20240529-00224版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。
注:中标率采用2000年中国标准人口年龄构成;老年人群定义为≥60岁
时期(年) | 60~64岁 | 65~69岁 | 70~74岁 | 75~79岁 | 80+岁 | 合计 |
---|---|---|---|---|---|---|
1972—1981 | 555.41 | 590.10 | 811.52 | 783.42 | 805.98 | 672.65 |
1982—1991 | 487.67 | 666.83 | 802.13 | 904.23 | 819.54 | 688.44 |
1992—2001 | 485.74 | 611.92 | 780.23 | 889.40 | 811.19 | 671.51 |
2002—2011 | 413.82 | 665.10 | 911.41 | 1 187.50 | 1 333.92 | 814.24 |
2012—2021 | 385.42 | 505.51 | 721.64 | 1 213.28 | 1 705.32 | 803.33 |
1972—2021 | 443.86 | 591.48 | 797.33 | 1 058.86 | 1 288.83 | 752.08 |
注:老年人群定义为≥60岁
时期(年) | 全部老年恶性肿瘤死亡例数 | 肺癌 | 胃癌 | 肝癌 | 结直肠癌 | 食管癌 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
例数 | 占比(%) | 例数 | 占比(%) | 例数 | 占比(%) | 例数 | 占比(%) | 例数 | 占比(%) | ||||||
1972—1981 | 7 058 | 1 041 | 14.7 | 2 188 | 31.0 | 1 136 | 16.1 | 375 | 5.3 | 678 | 9.6 | ||||
1982—1991 | 9 146 | 1 795 | 19.6 | 2 619 | 28.6 | 1 299 | 14.2 | 634 | 6.9 | 775 | 8.5 | ||||
1992—2001 | 12 469 | 2 780 | 22.3 | 2 625 | 21.1 | 2 388 | 19.2 | 984 | 7.9 | 884 | 7.1 | ||||
2002—2011 | 18 893 | 5 286 | 28.0 | 2 908 | 15.4 | 3 357 | 17.8 | 1 553 | 8.2 | 1 113 | 5.9 | ||||
2012—2021 | 27 157 | 7 595 | 28.0 | 3 237 | 11.9 | 3 764 | 13.9 | 2 660 | 9.8 | 1 050 | 3.9 | ||||
合计 | 74 723 | 18 497 | 24.8 | 13 577 | 18.2 | 11 944 | 16.0 | 6 206 | 8.3 | 4 500 | 6.0 | ||||
时期(年) | 全部老年恶性肿瘤死亡例数 | 胰腺癌 | 膀胱癌 | 女性乳腺癌 | 淋巴瘤 | 脑肿瘤 | |||||||||
例数 | 占比(%) | 例数 | 占比(%) | 例数 | 占比(%) | 例数 | 占比(%) | 例数 | 占比(%) | ||||||
1972—1981 | 7 058 | 320 | 4.5 | 83 | 1.2 | 114 | 1.6 | 95 | 1.3 | 45 | 0.6 | ||||
1982—1991 | 9 146 | 496 | 5.4 | 163 | 1.8 | 155 | 1.7 | 124 | 1.4 | 76 | 0.8 | ||||
1992—2001 | 12 469 | 534 | 4.3 | 290 | 2.3 | 254 | 2.0 | 198 | 1.6 | 196 | 1.6 | ||||
2002—2011 | 18 893 | 1 031 | 5.5 | 456 | 2.4 | 362 | 1.9 | 318 | 1.7 | 358 | 1.9 | ||||
2012—2021 | 27 157 | 1 891 | 7.0 | 733 | 2.7 | 681 | 2.5 | 610 | 2.2 | 511 | 1.9 | ||||
合计 | 74 723 | 4 272 | 5.7 | 1 725 | 2.3 | 1 566 | 2.1 | 1 345 | 1.8 | 1 186 | 1.6 |
注:老年人群定义为≥60岁
注:老年人群定义为≥60岁;中标率采用2000年中国标准人口年龄构成
恶性肿瘤 类别 | AAPC(%) | 趋势段1 | 趋势段2 | 趋势段3 | |||||
---|---|---|---|---|---|---|---|---|---|
时期(年) | APC(%) | 时期(年) | APC(%) | 时期(年) | APC(%) | ||||
全部 | 0.22(0.05~0.39) a | 1972—2002 | -0.14(-0.44~0.16) | 2002—2008 | 3.83(0.36~7.42) a | 2008—2021 | -1.59(-2.23~-0.94) a | ||
肺癌 | 1.61(1.27~1.95) a | 1972—2011 | 2.53(2.20~2.86) a | 2011—2021 | -2.31(-3.65~-0.96) a | - | - | ||
胃癌 | -2.36(-2.61~-2.11) a | 1972—1975 | 12.62(-6.11~35.07) | 1975—1989 | -1.50(-3.04~0.06) | 1989—2021 | -2.82(-3.18~-2.46) a | ||
肝癌 | -0.10(-0.52~0.32) | 1972—2008 | 1.14(0.69~1.60) a | 2008—2021 | -4.16(-5.60~-2.69) a | - | - | ||
结直肠癌 | 1.44(1.13~1.76) a | 1972—2021 | 1.44(1.13~1.76) a | - | - | - | - | ||
食管癌 | -2.03(-2.36~-1.71) a | 1972—2008 | -1.35(-1.80~-0.91) a | 2008—2021 | -4.82(-6.58~-3.02) a | - | - | ||
胰腺癌 | 1.38(0.92~1.85) a | 1972—1998 | -1.28(-1.82~1.28) | 1998—2021 | 2.59(1.49~3.71) a | - | - | ||
膀胱癌 | 1.30(0.76~1.83) a | 1972—2011 | 2.11(1.29~2.93) a | 2011—2021 | -1.97(-5.09~1.25) | - | - | ||
女性乳腺癌 | 1.49(1.04~1.93) a | 1972—2021 | 1.49(1.04~1.93) a | - | - | - | - | ||
淋巴瘤 | 1.61(1.08~2.13) a | 1972—2021 | 1.61(1.08~2.13) a | - | - | - | - | ||
脑肿瘤 | 2.30(1.63~2.97) a | 1972—2005 | 4.86(3.75~5.99) a | 2005—2021 | -1.05(-2.59~0.51) | - | - |
注: a P<0.05;AAPC为平均年度变化百分比;APC为年度变化百分比;()内为95% CI;-为无数据;老年人群定义为≥60岁; 中标率采用2000年中国标准人口年龄构成
陈永胜:数据收集、论文撰写;王军:数据整理、统计学分析;唐小慧:数据整理、论文修改;朱健:研究指导、论文修改、经费支持

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。